Saakshi Medtech and Panels Approves Audited Financial Results for Fiscal Year 2026

Saakshi Medtech and Panels Approves Audited Financial Results for Fiscal Year 2026

Saakshi Medtech and Panels Approves Audited Financial Results for Fiscal Year 2026​

Saakshi Medtech and Panels Limited announced that its Board of Directors approved the Audited Standalone Financial Results for the half year and the full financial year ended March 31, 2026. The financial statements were audited by M/s. Kishor Gujar and Associates, Chartered Accountants, who issued audit reports with an unmodified opinion on the results.

The company's performance and financial position were detailed in statements covering the period up to March 31, 2026, compared to the corresponding figures for 2025.

Financial Position Snapshot​

The company's Statement of Audited Assets and Liabilities provides a comparison of its financial health across the years.

ParticularsAs at 31 March 2026 (Rs. In Lakhs)As at 31 March 2025 (Rs. In Lakhs)
I. EQUITY AND LIABILITIES
Share Capital1,765.601,765.60
Reserves and Surplus9,267.848,038.87
Total Equity & Liabilities11,033.449,804.47
Long-term Borrowings1,613.821,404.73
Other Long-term Liabilities0.670.42
Long-term Provisions68.9761.62
Short-term Borrowings931.53377.62
Trade Payables (Due to Others)994.74721.22
Other Current Liabilities308.45255.59
Short-term Provisions680.01432.54
Total Equity & Liabilities15,698.6313,133.37
II. ASSETS
Property, Plant and Equipment8,300.325,938.91
Intangible Assets36.6069.53
Capital Work-in-progress987.901,320.14
Total Non-current Assets9,566.627,689.78
Inventories2,138.762,040.67
Trade Receivables2,624.502,188.47
Cash and cash equivalents179.61326.46
Total Current Assets6,132.025,443.58
TOTAL15,698.6313,133.37

Financial Performance Highlights​

The Statement of Audited Financial Results presented the company's operational and profit details for the half year and the full year.

Particulars31 March 2026 (Audited)30 September 2025 (Unaudited)31 March 2025 (Audited)31 March 2026 (Audited)31 March 2025 (Audited)
Revenue from Operations5,719.385,831.264,797.4311,550.649,243.11
Other Income22.2531.5529.6353.8057.22
Total Income5,741.635,862.814,827.0711,604.449,300.33
Total expenses4,958.714,979.024,646.359,937.738,641.48
Profit/(Loss) before Tax782.92883.79180.721,666.71658.85
Total Tax Expenses216.96220.7854.81437.74187.86
Profit/(Loss) for the period565.96663.01125.911,228.97470.99
Earnings Per Share (Basic)3.213.760.716.962.67

Cash Flow Analysis​

The audited statement of cash flow revealed the sources and uses of cash for the period.

Activity31 March 2026 (Rs. In Lakhs)30 September 2025 (Rs. In Lakhs)
A) CASH FLOW FROM OPERATING ACTIVITIES:
Net Profit before tax1,666.71658.85
Operating profit before working capital changes2,254.251,034.41
Cash generated from operations2,220.36515.36
Less: Income Taxes paid462.00213.10
Net cash flow from operating activities1,758.36302.26
B) CASH FLOW FROM INVESTING ACTIVITIES:
Purchase of Fixed Assets including of CWIP(2,463.15)(1,500.45)
Advance paid for purchase of fixed Assets(103.96)(19.55)
Net cash flow from investing activities(2,534.11)(1,474.13)
C) CASH FLOW FROM FINANCING ACTIVITIES:
Net Proceeds/(Repayment) of Short Term Borrowings553.9180.12
Net Proceeds/(Repayment) of Long Term Borrowings209.09(99.25)
Net cash flow from financing activities628.24(59.65)
Net Increase/(Decrease) In Cash & Cash Equivalents Total(147.50)(1,231.52)

The company’s overall cash flow for the period reflected a net decrease in cash and cash equivalents. The cash flow generated from operating activities totaled 1,758.36 Rs. in Lakhs for the year ended March 31, 2026. Investing activities, notably the purchase of fixed assets, resulted in a net cash outflow of 2,534.11 Rs. in Lakhs.

SAAKSHI Stock Price Movement​

Today, Saakshi Medtech and Panels Limited shares edged higher, settling at ₹231.3 after gaining 0.57% in trading today. The equity saw a total traded volume of 7,200 shares, adding to the positive momentum across the sector.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top